Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography

Table 1 Appearances and visual grades of tumor contrast enhancement of hemangiomas on gadolinium-ethoxybenzyl-diethylenetriaminpentaacetic acid-enhanced magnetic resonance imaging and enhanced computed tomography

Appearance	Tumors		P value
	Gd-EOB-DTPA-enhanced MRI	Enhanced CT
Peripheral nodular enhancement	52 (85)	50 (82)	0.7541
Central nodular enhancement	2 (3)	2 (3)	1.0001
Diffuse homogenous enhancement	7 (11)	10 (16)	0.5081
Arterioportal shunt	14 (23)	21 (34)	0.0651
Fill-in enhancement	48 (79)	49 (80)	1.0001
Prolonged enhancement	32 (52)	61 (100)	< 0.0011
Visual grade
Arterial phase	3.94 ± 0.98	4.57 ± 0.64	< 0.0012
Portal venous phase	3.72 ± 0.82	4.36 ± 0.53	< 0.0012
Equilibrium phase	2.01 ± 0.95	4.04 ± 0.51	< 0.0012

Data are presentd as mean ± SD or n (%).

¹P value between gadolinium-ethoxybenzyl-diethylenetriaminpentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) and enhanced computed tomography (CT) by a McNemar test;

²P value between Gd-EOB-DTPA-enhanced MRI and enhanced CT by a Wilcoxon’s signed rank test.